| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0001085146-21-001720 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 884546 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 10739 | 285058 | SH | SOLE | 285058 | 0 | 0 | May 4th, 2022 04:12PM | May 4th, 2022 04:12PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0001085146-21-001703 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1107261 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 1944 | 51600 | SH | SOLE | 42800 | 0 | 8800 | May 4th, 2022 04:12PM | May 4th, 2022 04:12PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0001068837-21-000004 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | VOYA INVESTMENT MANAGEMENT LLC | 1068837 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 536 | 14235 | SH | DFND | 1,5,3 | 0 | 0 | 14235 | May 4th, 2022 04:12PM | May 4th, 2022 04:12PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0001062993-21-004710 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | Polar Asset Management Partners Inc. | 1326389 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 7181 | 190641 | SH | SOLE | 190641 | 0 | 0 | May 4th, 2022 04:11PM | May 4th, 2022 04:11PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0001062993-21-004685 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | CAPTRUST FINANCIAL ADVISORS | 1512024 | FIVE PRIME THERAPEUTICS INC COM | Common Stock | 33830X104 | 53 | 1396 | SH | SOLE | 1396 | 0 | 0 | May 4th, 2022 04:11PM | May 4th, 2022 04:11PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0000950123-21-007021 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | CITADEL ADVISORS LLC | 1423053 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 595 | 15800 | SH | Put | DFND | 1 | 15800 | 0 | 0 | May 4th, 2022 04:10PM | May 4th, 2022 04:10PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0000950123-21-007021 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | CITADEL ADVISORS LLC | 1423053 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 396 | 10500 | SH | Call | DFND | 1 | 10500 | 0 | 0 | May 4th, 2022 04:10PM | May 4th, 2022 04:10PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0000950123-21-006955 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 932859 | FIVE PRIME THERAPEUTICS INC | Common Stock | 33830X104 | 2901 | 77021 | SH | SOLE | 65331 | 0 | 11690 | May 4th, 2022 04:09PM | May 4th, 2022 04:09PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0000950123-21-006907 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | BALYASNY ASSET MANAGEMENT LLC | 1218710 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 2655 | 70485 | SH | SOLE | 70485 | 0 | 0 | May 4th, 2022 04:09PM | May 4th, 2022 04:09PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:fprx | nasdaq:fprx Shareholders | 13F-HR | 0000950123-21-006877 | Mar 31st, 2021 12:00AM | May 17th, 2021 12:00AM | May 17th, 2021 12:00AM | Nuveen Asset Management, LLC | 1521019 | FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 643 | 120338 | SH | DFND | 4 | 120338 | 0 | 0 | May 4th, 2022 04:08PM | May 4th, 2022 04:08PM | Five Prime Therapeutics | Health Care | Pharmaceuticals & Biotechnology |